The GV and Wuxi AppTec-backed drug development software producer floated above its range and saw its shares rise 68% on their first day of trading.

Schrödinger, a US-based life sciences software provider that counts pharmaceutical firm Wuxi AppTec and internet and technology group Alphabet as investors, went public yesterday in a $202m initial public offering. The IPO consisted of almost 11.9 million shares priced at $17.00 each, above the $14 to $16 range the company set last week. The company’s…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.